Table 1 Characteristics of five study subjects with large central scars and visual improvement between months 3 and 12

From: Improvement in corneal scarring following bacterial keratitis

ID

Age

Sex

SCUT Tx

Organism

BSCVA

BCLVA

     

0 Month

3 Months

12 Months

3 Months

12 Months

1

50

F

Placebo

S. pneumoniae

CF

20/159

20/38

20/69

20/29

2

43

M

Placebo

S. pneumoniae

HM

20/240

20/66

20/132

20/55

3

63

M

Steroid

S. pneumoniae

CF

20/289

20/69

20/289

20/42

4

65

M

Steroid

S. pneumoniae

CF

20/96

20/28

20/80

20/25

5

30

F

Steroid

P. aeruginosa

HM

20/145

20/26

20/126

20/24

  1. BCLVA, best visual acuity after correction with rigid gas permeable contact lens; BSCVA, best spectacle–corrected visual acuity; CF, counting fingers; HM, hand motions; SCUT Tx, treatment group in the Steroids for Corneal Ulcers Trial.3, 4
Back to article page